rs776798195
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000166.6(GJB1):c.438G>A(p.Glu146Glu) variant causes a synonymous change. The variant allele was found at a frequency of 0.00000998 in 1,202,929 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.0000082 ( 0 hom. 2 hem. )
Consequence
GJB1
NM_000166.6 synonymous
NM_000166.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.28
Publications
0 publications found
Genes affected
GJB1 (HGNC:4283): (gap junction protein beta 1) This gene encodes a member of the gap junction protein family. The gap junction proteins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene cause X-linked Charcot-Marie-Tooth disease, an inherited peripheral neuropathy. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2008]
GJB1 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth disease X-linked dominant 1Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)
- X-linked progressive cerebellar ataxiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant X-71224145-G-A is Benign according to our data. Variant chrX-71224145-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 406231.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GJB1 | NM_000166.6 | c.438G>A | p.Glu146Glu | synonymous_variant | Exon 2 of 2 | ENST00000361726.7 | NP_000157.1 | |
| GJB1 | NM_001097642.3 | c.438G>A | p.Glu146Glu | synonymous_variant | Exon 2 of 2 | NP_001091111.1 | ||
| GJB1 | NM_001440770.1 | c.438G>A | p.Glu146Glu | synonymous_variant | Exon 3 of 3 | NP_001427699.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000272 AC: 3AN: 110358Hom.: 0 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
3
AN:
110358
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00000593 AC: 1AN: 168635 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
168635
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000824 AC: 9AN: 1092571Hom.: 0 Cov.: 32 AF XY: 0.00000558 AC XY: 2AN XY: 358527 show subpopulations
GnomAD4 exome
AF:
AC:
9
AN:
1092571
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
358527
show subpopulations
African (AFR)
AF:
AC:
1
AN:
26348
American (AMR)
AF:
AC:
1
AN:
34412
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19255
East Asian (EAS)
AF:
AC:
0
AN:
30037
South Asian (SAS)
AF:
AC:
0
AN:
53103
European-Finnish (FIN)
AF:
AC:
0
AN:
40079
Middle Eastern (MID)
AF:
AC:
0
AN:
4132
European-Non Finnish (NFE)
AF:
AC:
7
AN:
839290
Other (OTH)
AF:
AC:
0
AN:
45915
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000272 AC: 3AN: 110358Hom.: 0 Cov.: 22 AF XY: 0.0000307 AC XY: 1AN XY: 32620 show subpopulations
GnomAD4 genome
AF:
AC:
3
AN:
110358
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
32620
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30296
American (AMR)
AF:
AC:
1
AN:
10341
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2639
East Asian (EAS)
AF:
AC:
0
AN:
3492
South Asian (SAS)
AF:
AC:
0
AN:
2535
European-Finnish (FIN)
AF:
AC:
0
AN:
5960
Middle Eastern (MID)
AF:
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
AC:
2
AN:
52716
Other (OTH)
AF:
AC:
0
AN:
1469
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth disease Uncertain:1
Mar 03, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Charcot-Marie-Tooth Neuropathy X Benign:1
Sep 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.